España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Terns Pharma
TERN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$6.86
0.14
2.08%
At Close: -
$7.00
0.14
2.04%
After Hours: 1:00 PM EDT
15 minutes delayed
Get Report
Watch
Terns Pharma (TERN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Terns Pharma (NASDAQ:TERN) Stock
Terns Pharma Stock (NASDAQ: TERN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 24, 2024
Terns Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Reported Earlier, Terns Pharmaceuticals Unvei...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Neutral on Ter...
Benzinga Newsdesk
Monday, May 13, 2024
Terns Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Terns Pharma Q1 2024 GAAP EPS $(0.30) Beats $...
Benzinga Newsdesk
Tuesday, April 30, 2024
HC Wainwright & Co. Reiterates Neutral on Ter...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, April 29, 2024
Terns Pharmaceuticals Announces Data from Ong...
Benzinga Newsdesk
Wednesday, March 27, 2024
UBS Maintains Buy on Terns Pharma, Lowers Pri...
Benzinga Newsdesk
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, March 18, 2024
Terns Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
JMP Securities Maintains Outperform on Terns ...
Benzinga Newsdesk
Friday, March 15, 2024
BMO Capital Maintains Outperform on Terns Pha...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Ter...
Benzinga Newsdesk
Thursday, March 14, 2024
Terns Pharma Q4 EPS $(0.29), Inline
Happy Mohamed
Monday, March 11, 2024
Terns Pharmaceuticals Secures FDA Orphan Drug...
Benzinga Newsdesk
Friday, February 09, 2024
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, February 07, 2024
Terns Pharmaceuticals Appoints Amy Burroughs ...
Benzinga Newsdesk
Wednesday, January 10, 2024
HC Wainwright & Co. Maintains Neutral on Tern...
Benzinga Newsdesk
Tuesday, December 05, 2023
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
Lisa Levin
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday
Lisa Levin
Monday, November 27, 2023
Mizuho Maintains Buy on Terns Pharma, Lowers ...
Benzinga Newsdesk
Tuesday, November 14, 2023
Recap: Terns Pharma Q3 Earnings
Benzinga Insights
Terns Pharma Q3 EPS $(0.42) Vs $(0.44) YoY, C...
Benzinga Newsdesk
Monday, November 13, 2023
Terns Pharmaceuticals Presents Data From Phas...
Benzinga Newsdesk
Thursday, November 02, 2023
Terns Pharmaceuticals Announces First Partici...
Benzinga Newsdesk
Monday, October 16, 2023
Terns Pharmaceuticals Announces Global Phase ...
Benzinga Newsdesk
Thursday, August 10, 2023
Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
HC Wainwright & Co. Maintains Neutral on Tern...
Benzinga Newsdesk
Wednesday, August 09, 2023
Terns Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
JP Morgan Maintains Neutral on Terns Pharma, ...
Benzinga Newsdesk
Tuesday, August 08, 2023
Terns Pharma Q2 EPS $(0.25) Beats $(0.34) Est...
Benzinga Newsdesk
Terns Achieves Primary Endpoint And All Secondary Endpoints In Phase 2a DUET Trial Of THR-β Agonist TERN-501 In NASH
Happy Mohamed
Roth MKM Reiterates Buy on Terns Pharma, Main...
Benzinga Newsdesk
Thursday, August 03, 2023
Terns Pharmaceuticals Announces CEO Senthil S...
Benzinga Newsdesk
Wednesday, July 26, 2023
12 Analysts Have This to Say About Terns Pharma
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, June 30, 2023
Roth MKM Reiterates Buy on Terns Pharma, Main...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Mizuho Reiterates Buy on Terns Pharma, Mainta...
Benzinga Newsdesk
Wednesday, June 28, 2023
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
Vandana Singh
Tuesday, June 27, 2023
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Terns Pharmaceuticals shares are trading lowe...
Benzinga Newsdesk
Mizuho Reiterates Buy on Terns Pharma, Mainta...
Benzinga Newsdesk
Monday, June 26, 2023
Terns Pharmaceuticals Highlights New Preclinical Data For TERN-601 Program In Obesity At The ADA's 83rd Annual Scientific Session And Upcoming Events
Happy Mohamed
Thursday, June 22, 2023
Expert Ratings for Terns Pharma
Benzinga Insights
Terns Pharma Has 35% Upside According To This Analyst, NASH Asset To Drive Valuation
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
